S-100 for monitoring melanoma – pro
Two tumor markers are usually used for the monitoring of patients with melanoma, the proteins S100 and melanoma-inhibitory activity (MIA). S100 represents a family of calcium-binding proteins differentially expressed in a large variety of tissues Hauschild et al. showed that serum S100 indeed correlates with the clinical course in patients with advanced-stage melanoma. Moreover, the German melanoma guidelines recommend serum S100 measurement in patients with melanoma, highlighting its reliability in melano
UGUR USL et al, Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells, Anticancer Research September 2017 vol. 37 no. 9 5033-5037
Xiong, Ting-feng; Pan, Fu-qiang; Li, Dong, , Expression and clinical significance of S100 family genes in patients with melanoma. Melanoma Research: February 2019 – Volume 29 – Issue 1 – p 23-29